Group 1 - Xiao Fang Pharmaceutical (603207.SH) released its semi-annual report for 2025 on August 26, 2025, indicating that as of August 25, 2025, 17 institutional investors held a total of 115 million shares, accounting for 71.90% of the total share capital [1] - The top ten institutional investors collectively held 71.38% of the shares, with a slight decrease of 0.77 percentage points compared to the previous quarter [1] - The top institutional investors include companies such as Yunjia Far East Co., Ltd., Jiaxing Youjia Enterprise Management Partnership, and Guoxin Capital Co., Ltd. [1] Group 2 - In the public fund sector, three new public funds were disclosed this period, including CITIC Securities Rotation Mixed A, CITIC Securities Selection Mixed A, and Hongta Hongtu Shengshang One-Year Regular Open Bond A [2] - Two public funds were not disclosed in this period compared to the previous quarter, including Taixin Industry Selection Mixed A and Ping An MSCI China A-Shares Low Volatility ETF [2]